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6584 | Chem. Sci., 2019, 10, 6584–659nd implementation of a cucurbit
[8]uril-based indicator-displacement assay for
application in blood serum†
Stephan Sinn, a Eduard Spuling, b Stefan Bra¨se bc and Frank Biedermann *a
In this study, we report the ﬁrst supramolecular indicator-displacement assay (IDA) based on cucurbit[n]uril
(CBn) hosts that is operational in blood serum. Rational design principles for host–guest chemosensing in
competitively binding media were derived through detailed mathematical simulations. It was shown that
currently known CBn-based chemosensing ensembles are not suited for use in highly competitive
matrices such as blood serum. Conversely, the simulations indicated that a combination of cucurbit[8]
uril (CB8) and an ultra-high aﬃnity dye would be a promising IDA reporter pair for the detection of
Alzheimer's drug memantine in blood serum. Therefore, a novel class of [2.2]paracyclophane-derived
indicator dyes for the host CB8 was developed that possesses one of the highest host–guest aﬃnities
(Ka > 10
12 M1 in water) known in supramolecular host–guest chemistry, and which provides a large
Stokes shift (up to 200 nm). The novel IDA was then tested for the detection of memantine in blood
serum in a physiologically relevant sub- to low micromolar concentration range.Background
It is one great promise of supramolecular chemistry that low-
cost and chemically & thermally robust articial receptors can
complement contemporary antibody-based assays and chro-
matographic analytical methods in real-world sensing applica-
tions, e.g. for medical diagnostics.1–4 For instance, options for
regular monitoring of drug levels in the blood of patients can
assist the development of personalized medicine, taking indi-
vidual drug bioavailability characteristics into account.5
Besides, quick and low-cost access to drug levels in biouids
can help medical staﬀ to evaluate whether patients comply with
the prescribed drug treatment. However, most synthetic
supramolecular sensing methods face great challenges in bio-
uids, especially blood serum, because of the presence of salts,
sugars, lipids, hormones, proteins, etc. that can act as
competitive binders for the generally rather unselective arti-
cial hosts (Fig. 1).6–8 In addition, strong absorbance and emis-
sion of blood over a wide wavelength range imposes additional
diﬃculties.8 Lastly, for a real application, one would have toFig. 1 (A) Schematic representation of a direct-binding assay (DBA)
utilizing a ﬂuorescent host. (B) Schematic representation of an indi-
cator-displacement assay (IDA) utilizing an indicator to precedingly
form the reporter pair with a spectroscopically silent host and
a subsequent displacement by the analyte. (C) Matrix eﬀects perturb
the application in complex media (blood) of unspeciﬁc binding assays
by virtue of competitive binding. Left: Matrix-independent assay
without perturbance by matrix variations (feasible with MPCP). (D)
Matrix-dependent assay with known reporters.
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Fig. 2 (A) The chemical structure of cucurbit[8]uril (CB8), the high-
aﬃnity unspeciﬁc host, and the Alzheimer's drug memantine hydro-
chloride (Mem), the analyte used in this study. (B) Published 1 : 1
binding ﬂuorescent IDA dyes for CB8: PMI-OH,39 PMI-Phe,40 PDI,41–43
DAE44 and the novel high-aﬃnity dye (MPCP) presented in this work.
Their logarithmic binding constants with CB8 in aqueous media and
the excitation and emission wavelength maxima of the CB8Idye
complex are displayed.
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View Article Onlineconsider that the matrix could change (e.g., the blood compo-
sition varies from one person to another). These changes could
aﬀect the sensor response independently of the concentration
of analytes of interest.9
Thus, despite many proof-of-principle reports in organic
solvents and in low-salt aqueous buﬀers,1,10–14 only a few
supramolecular sensing systems are to date operational in
blood serum in a practically relevant concentration range, e.g.
the detection and quantication of alkaline metal cations (mM
conc. range),15–17 of glucose (15 mM conc.),18 phosphate, pyro-
phosphate, AMP, or ATP (5 mM conc.)19 and of carnosine and
homocarnosine (ca. 25 mM conc. in deproteinized human blood
serum).9
The therapeutic window of many drugs is in the nanomolar
to micromolar range. To illustrate, for Alzheimer's drug mem-
antine (Mem)20 (Fig. 2A) the relevant plasma concentration
range is between 0.03 and 1 mM.21,22 This implies that the
binding aﬃnity, Ka, of an articial receptor for the analyte to be
detected in blood serum should reach at least 106 M1. Out of
the many known supramolecular hosts, the macrocyclic
cucurbit[n]urils (CBn, n ¼ 5–10),23–28 see Fig. 2A, are particularly
promising building blocks for the construction of chemo-
sensors as they strongly bind a range of bio-relevant organic
compounds.3,29–35 Three main sensing strategies that were
adopted for CBn-based sensing studies are: (i) Direct-binding
assays (DBA) where CBn-derivatives containing a remotely
attached or framework-incorporated dye component yield
a spectroscopic response upon binding of an analyte to the
cavity (Fig. 1A).3,36,37 (ii) Associative-binding assays (ABA) for the
detection of aromatic analytes. Note that the ABA, for which the
binding cavity is formed by the host and a non-covalently
incorporated reporter dye, is conceptually akin to a DBA.3,29,30
(iii) Indicator-displacement assays, IDAs, where an environ-
ment-sensitive indicator (e.g. an emissive or chromophoric
reporter dye) is pre-complexed with CBn or its derivatives. If
a host-binding analyte (e.g. memantine) is present in the
medium, then the indicator is displaced, generating a readily
measurable and quantiable spectroscopic change
(Fig. 1B).1,3,10–13,38
Regardless of the sensing method chosen, one will generally
aim to obtain a linear signal–concentration response curve with
a large slope, and which is not aﬀected by naturally occurring
sample-to-sample diﬀerences in the matrix composition in virtue
of competitive interactions (Fig. 1C). In contrast, there are unac-
ceptable large errors when correlating the measured signal with
an apparent analyte concentration if the chemosensor is aﬀected
by thematrix and by sample-to-samplematrix variations (Fig. 1D).
In this contribution, we will show that only the IDA format
and not a DBA holds promise for sensing in blood serum at
physiologically relevant concentrations using high-aﬃnity but
unselective cucurbit[n]uril-based chemosensors. Moreover, it
will be discussed that ultra-high-aﬃnity indicator dyes for CB8
are needed to enable sensing in blood serum. Based on these
guidelines, the rst member of a [2.2]paracyclophane-based dye
family is introduced and its utility for memantine-sensing in
blood serum is demonstrated.This journal is © The Royal Society of Chemistry 2019Results and discussion
General considerations for a memantine-sensing assay in
complex media containing competitive binders
Memantine is an interesting starting point for establishing
a drug-monitoring assay in blood serum because patients with
dementia oen fail to comply with the prescribed medication
regimens.45 A large variance of memantine concentrations was
found in clinical studies, which justies regular monitoring of
memantine concentration in order to reduce adverse drug
eﬀects such as confusion.46 However, the chromatographic
methods used for the quantication of memantine require
time-consuming sample preparation procedures;47,48 such
assays are not suitable for regular use in point of care units.
In the rst step, we set to analyze and compare in detail the
diﬀerent sensing assay formats by taking use of mathematicalChem. Sci., 2019, 10, 6584–6593 | 6585
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View Article Onlinesimulations of binding isotherms.We wonderedwhether a direct-
binding assay (Fig. 3A), utilizing a chromophoric CB8 derivative
whose emission signal is quenched (or enhanced) upon analyte
binding, would be the simplest route for the detection of spec-
troscopically silent analytes such as memantine. Indeed, the
desired linear signal–concentration response curve is obtained in
this assay type if rather “innocent”matrices such as water or low-
salt buﬀers are considered as the medium (Fig. 3A, black dashed
line). However, the low binding selectivity of CBn – and many
other synthetic hosts – is the crucial limiting factor.3 For instance,
endogenously present metabolites in blood such as amino acids
Phe, Trp, Lys, Arg and ornithine (each occurring in the range of 20
to 200 mM)49 and hormones, e.g. cortisol (0.3 to 1.1 mM)47 are
strong CBn-binders, see Fig. 6 for details.3,33,35 Besides, cations,
such as Na+, K+ and Ca2+ which are present in the highmillimolar
range in urine50 and blood serum,51 show millimolar to micro-
molar aﬃnities for CBn.52,53Fig. 3 Simulations of the eﬀect of blood matrix interferents on the
CB8–memantine binding assay performance, comparing the lowest
concentration limits of the interferents (dashed lines) and the highest
limit (solid line) for blood serummatrices. See text and ESI† for details.
(A) CB8-based direct-binding assay in the absence and presence of
interferents in the matrix. (B) IDA featuring indicator dyes with log Ka#
9 for CB8. (C) IDA featuring indicator dyes with log Ka $ 10 for CB8.
6586 | Chem. Sci., 2019, 10, 6584–6593When carrying out the mathematical binding isotherm
simulation for DBA in the simultaneous presence of nine serum
components that are binders for CB8, it becomes clear that a CB8-
chemosensor would be nearly quantitatively complexed by the
interferents (Fig. 3A, see ESI† for details). Therefore, the presence
or absence of the target analyte memantine would only yield
a very small spectroscopic response with a much smaller slope
compared to the situation without a competitively binding
matrix. Moreover, the response curves are also sample-dependent
(solid and dotted red lines in Fig. 3A and in the zoom-in shown in
Fig. S1 and S2 see ESI†), which is problematic because the
absolute and relative concentration of blood components varies
both from patient to patient and during time. The simulated
results for the DBA in the presence of competitively binding
matrix components are therefore akin to the undesirable matrix-
dependent situation sketched in Fig. 1D. The direct-binding assay
format appears to be not useful for application in blood serum
when utilizing unselectively binding CBn-type hosts.Performance of an IDA in the presence of competitive binders
We then turned our attention to the IDA format with CB8–dye
combinations as the chemosensing ensemble for the detection
of memantine in blood serum.
Mathematical simulations were carried out to analyse the
behaviour of CB8Idye chemosensing ensembles of varying
binding aﬃnity (log Ka ¼ 4 to 15) in a competitively binding
matrix upon increase of the memantine concentration (Fig. 3B
and C). The following general observations were made: for a low
aﬃnity indicator dye (log Ka # 9), both interferents and the
analyte cause a signicant amount of dye displacement (Fig. 3B).
Specically, it is clear that CB8-indicator dyes with log Ka# 7 are
generally not expected to be of use for IDA sensing applications in
blood serum because the CB8Idye chemosensing ensemble is
$50% decomplexed by the interferents. For log Ka # 8 to 9, the
chemosensing integrity is near 80% and 90%, respectively, which
may be suﬃciently high to conduct an IDA in blood serum.
However, signicant sample-to-sample matrix variation inu-
ences have to be expected in particular in the low but physio-
logically most relevant memantine concentration range,
preventing an accurate concentration determination of mem-
antine (Fig. 3B and zoom-in shown in Fig. S4–S6†). In short, the
IDA in blood serum based on CB8Idye combinations with an
aﬃnity of log Ka # 9 will likely result in undesirable signal–
response curves similar to those shown in Fig. 1D.
Conversely, for an ultra-high aﬃnity dye, both the interfer-
ents and the analyte will not appreciably displace the dye, and
thus, there will be no undesirable matrix eﬀects but also only
a weak signal change in the presence of the analyte. Specically,
for log Ka $ 14, the degree of CB8Idye complexation is nearly
quantitative but now the simulated signal response curves
become too at (Fig. 3C). Between the borders of too weakly and
too strongly binding indicator dyes, one suspects to nd an
aﬃnity range for which the matrix eﬀects are small, but for
which the signal–response curve in the presence of the analyte
is linear and steep. Indeed, the “sweet spot” is reached for
indicator dyes with a log Ka range of 10–13. Under theseThis journal is © The Royal Society of Chemistry 2019
Fig. 4 (A) Geometry-optimized DFT model of the ground-state of
CB8IMPCP featuring an ideal packing coeﬃcient (PC) of 57%. (B)
Fluorescence spectra of MPCP (lexc ¼ 335 nm, lem ¼ 535 nm, c ¼ 1.9
mM) in water with increasing CB8 concentration (0–3.1 mM). The ob-
tained binding isotherm (inset) allows us to deduce the stoichiometry
(1 : 1) and the assessment of a very strong binding (log Ka $ 9) (for
accurate determination of Ka see Fig. 5 and Table 1).
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View Article Onlinecircumstances, a linear, steep signal–response curve is seen that
is unaﬀected by matrix eﬀects and sample-to-sample variations.
This situation is akin to the ideal supramolecular sensing curve
depicted in Fig. 1C; see also ESI† for numerical values.
Unfortunately, contemporarily known 1 : 1 binding emissive
indicator dyes for CB8 possess maximal aﬃnities in the range of
104 < Ka < 10
8 M1 in water, see Fig. 2B, and therefore are inside
the undesirable low-aﬃnity range. We therefore gured that
rst a new emissive indicator dye for CB8 has to be designed
that possesses an aﬃnity within the predicted ideal range of
1010 to 1013 M1 in water.
Design of a novel picomolar indicator dye for CB8
Screening the tabulated thermodynamic binding parameters of
a large number of CB8 guests showed that typical aromatic
components (e.g. typical chromophores) and cyclic and acyclic
aliphatic species (e.g. hydrocarbons, terpenes, steroids) do not
exceed Ka values of 109 M1.3 In contrast, suitable ultra-high-
aﬃnity binding moieties for CB8 are spherical in shape such as
metallocene complexes and adamantyl-species (e.g. mem-
antine) and bind the host in a 1 : 1 stoichiometry. Unfortu-
nately, they are themselves not emissive and it remains unclear
how reporter dyes that have suﬃcient photophysical properties
for sensing in blood serum (e.g. signal response factors, exci-
tation wavelength and large Stokes shi) can be constructed
from those moieties. We therefore searched for alternative
spherically shaped compounds that would be inherently chro-
mophoric and emissive. Inspired by the known, unique 2 : 1
homo- and 1 : 1 : 1 hetero-ternary complex formation of two
aromatic moieties in CB8, we rationalized that two covalently
tied aromatic rings, as found in [2.2]paracyclophane (PCP),
should feature as a strong binding motif for CB8. In order to
render the PCPmoiety emissive, the installation of a pyridinium
moiety onto the PCP backbone was carried out, targeting the
known charge-transfer type emission mechanism of folded
(phenylalkyl)pyridines.49 Besides, the positively charged pyr-
idinium moiety would also ensure aqueous solubility and
strengthen the binding aﬃnity.25,26,28,54 We therefore prepared
methyl-pyridinium-paracyclophane (MPCP, see Fig. 2B) as its
iodide salt by a sequence of bromination of [2.2]para-
cyclophane, Pd-catalyzed cross-coupling with 4-pyridyl boronic
acid and subsequent quaternization in an overall yield of 19%,
see the ESI† for details.55 Indeed, molecular modelling (see
Fig. 4A and ESI† for details) indicates a snug t of the PCP
moiety of MPCP in the CB8 cavity, arriving at a packing coeﬃ-
cient (PC) of 57%, which is spot-on in the ideal packing regime
of (55  9)% for supramolecular host–guest complexes.56,57 It is
worth noting that MPCP is largely selective for the larger host
CB8 over the smaller CB7 variant; the latter cannot engulf the
PCP moiety but only the smaller pyridinium moiety (see ESI†).
Experimental evaluation of CB8IMPCP host–guest
interactions
In the next steps, the binding properties ofMPCP with CB8 were
systematically evaluated. First, the CB8IMPCP binding geom-
etry was investigated by 1H NMR experiments in D2O. The
1HThis journal is © The Royal Society of Chemistry 2019NMR spectrum of MPCP shows two sets of aromatic peaks at
8.15–8.75 ppm (2  2 protons of the pyridinium core) and at
6.53–6.85 ppm (7 PCP protons), see Fig. S18.† The aliphatic
protons are at 4.38 ppm (CH3-Npy moiety) and at 2.57–3.40 ppm
(2 –CH2CH2– moieties of PCP). Upon addition of CB8, the
aromatic and aliphatic PCP protons experienced a large upeld
shi, indicating encapsulation of the PCP moiety inside the
cavity of CB8. The pyridinium proton signals were only slightly
upeld shied, while the methyl-pyridinium proton signals
remain rather unaﬀected. These ndings, which are in agree-
ment with molecular modelling results (Fig. 4A), conrm that
the [2.2]paracyclophane moiety ofMPCP is encapsulated inside
the CB8 cavity, while the methyl-pyridinium group is located
near the portal region of the host.
The aqueous solutions ofMPCP are emissive in the visible area
of the electromagnetic spectrum (lmax 550 nm, see Fig. 4B) and
possess a large Stokes shi (up to 200 nm) in polar and nonpolar
solvents, see Table S1 and photophysical spectra in the ESI.†
Investigation of the absorbance and emission properties ofMPCP
with respect to solvent polarity yielded a photophysical response
that is indicative of a charge-transfer type emission, in agreement
with the large Stokes shi in water (see ESI† for details). Upon
addition of CB8, the uorescence spectra display a 6.8 fold
increase in the emission intensity with a small hypsochromic
shi. The titration curve clearly shows a very strong MPCP–CB8
binding, supporting the expected 1 : 1 binding stoichiometry
(Fig. 4B) that was veried by absorbance-based titration and ESI-
MS experiments. Because the titration curves were very steep even
at nanomolar concentrations of dye and host, i.e. (Ka[ 10
9M1),
a competitive binding method was adopted for determining the
aﬃnity of the CB8IMPCP complex (Fig. 5A). To this end,
a measurement protocol and mathematical tting routine for
berberine chloride (BC) as an indicator and competitive 2 : 1
binder for CB8 was established that can be generally employed to
determine the aﬃnity of strong CB8 binders in aqueous media
(e.g. for amantadine, memantine see the ESI†). For the
CB8IMPCP complex, a remarkably high binding aﬃnity of Ka ¼
3.89 (0.99)  1012 M1 was obtained in deionized water (Table
1). Thus, MPCP is to date one of the strongest binding guests forChem. Sci., 2019, 10, 6584–6593 | 6587
Table 1 Thermodynamic data for host–guest interactions ofMem and
MPCP with CB8
Complex Medium Ka
a log Ka
b
CB8IMPCP Waterc 3.89 (0.99)  1012 M1 12.59 (0.02)
PBSd 7.55 (1.68)  1010 M1 10.88 (0.10)
CB8IMem Waterc 8.28 (0.38)  1012 M1 12.92 (0.02)
PBSd 1.33 (0.47)  1011 M1 11.12 (0.15)
a Binding aﬃnity obtained at T ¼ 25 C. b Decadic logarithm of Ka.
c Experiments were performed in MilliQ water. d Experiments were
performed in phosphate buﬀered saline (PBS) consisting of 137 mM
NaCl, 2.7 mM KCl, 10 mM Na2HPO4 and 2 mM KH2PO4.
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View Article OnlineCB8 in general and the strongest binding 1 : 1 complex forming
indicator dye for CB8. Indeed, even in phosphate buﬀer saline
(PBS) as a model for a biouid consisting of 137 mM NaCl, 2.7
mM KCl, 10 mM Na2HPO4 and 2 mM KH2PO4, the binding
aﬃnity ofMPCP for CB8 remained extremely high, 7.55 (1.68)
1010 M1. MPCP is therefore one of the strongest binding guests
known to date for CB8.53 Analogously, the binding aﬃnities of
Mem were determined to be Ka ¼ 8.28 (0.38)  1012 M1 in
deionized water and 1.33 (0.47)  1011 M1 in PBS using the
competitive binding method. For comparison, Isaacs and co-
workers found a value of Ka ¼ 4.3  1011 M1 in 50 mM NaO2-
CCD3 (pD ¼ 4.75) as determined by competitive NMR experi-
ments.58 We believe that the PCP dye class can be of further use
for determining the binding strength of spectroscopically silent,
ultra-high aﬃnity guests for CB8 such as diamantane53,59 in
a single uorescence-based titration experiment, complementing
current multi-step competition NMR-titration methods.Development of a CB8IMPCP-based IDA for memantine
detection in saline buﬀers and blood serum
The titration of CB8IMPCP with memantine was then carried
out in phosphate buﬀer saline (PBS) as a rst test whether an
IDA can be set up for the detection and quantication of
memantine in a “biological uid”. It is worth noting that
equilibration times can be very long (e.g. up to several days) for
ultra-high-aﬃnity receptor–ligand or host–guest systems, which
can be a serious drawback for a sensing application.60–62 For the
displacement of MPCP by Mem from CB8, we observed equili-
bration times of approximately 8 to 30 min upon increasing the
Mem concentration from 170 nM to 1 mM (Fig. 5B). Fortunately,
the equilibration times are well inside a practically convenient
range for an analytical assay. The data (0.00 mM trace in Fig. 5B)
also indicated that CB8IMPCP is suﬃciently photostable ($20Fig. 5 (A) Fluorescence-titration experiment derived binding isotherm of
462 nm, lem¼ 548 nm, cCB8¼ 0.6 mM, cBC¼ 59.2 mM) byMPCP (0–1 mM)
details. The logarithmic binding constants of CB8IMem were determ
repetitive titration experiments at T ¼ 25 C. (B) Fluorescence based kine
depicted) of the reversed indicator-displacement assay (RIDA) in PBS, in w
9.9 mM) is injected into a Mem spiked solution. Concentrations of Mem f
and 1.02 mM at T¼ 25 C. (C) Fluorescence based IDA of CB8IMPCP (lex
Mem (0–2 mM) in PBS, (grey dots) with a linear calibration curve, R2 ¼ 0.
curve, R2 ¼ 1.000 (red line). Determination of unknown Mem concent
calibration curve, T ¼ 25 C.
6588 | Chem. Sci., 2019, 10, 6584–6593min continuous irradiation in the spectrouorometer). We then
experimentally measured the emission response upon
increasing concentrations of Mem, covering a range from 0.05
to 2 mM, in PBS at a xed CB8IMPCP chemosensor concen-
tration of 9.7 mM. Pleasingly, the observed signal–concentration
response curve was highly linear, R2 ¼ 0.999, see Fig. 5C.
Encouraged by these results, we then turned our attention to
blood serum as the practically most relevant but challenging
biouid for assay development. In addition to the competitive
binding interferents present in blood serum, emission-based
sensing applications in blood serum are further complicated by
the strong absorbance and auto-emissive properties of this bio-
logical matrix. Fortunately, the novel indicator dye MPCP shows
a much larger Stokes shi than previously reported IDA dyes for
CB8, see Fig. 2B, assisting in reducing the emission background
signal from the blood serummatrix. Besides, low cost disposable
PMMA plastic cuvettes can be utilized with the CB8IMPCP
reporter pair. Fortunately, the excitation maximum of
CB8IMPCP around 335 nm coincides with a local absorbance
minimum of unltered and ltered blood sera (Fig. S20†),
enabling the development of the CB8IMPCP based IDA assay inthe displacement of berberine chloride (BC) from the CB8IBC2 (lexc¼
in PBS. The data were ﬁtted to a competitive binding assay, see ESI† for
ined to be log Ka ¼ 12.59 (water) and log Ka ¼ 10.88 (PBS) from ten
tic traces at varied concentrations of Mem (average of triple replica is
hich the reporter pair CB8IMPCP (lexc ¼ 335 nm, lem ¼ 535 nm, c ¼
or each curve (top to bottom, black to yellow): 0, 0.17, 0.25, 0.51, 0.75,
c¼ 335 nm, lem¼ 535 nm, c¼ 9.7 mM) with increasing concentration of
999 (black line) and in human serum (red dots) with a linear calibration
rations in human serum (blue squares) based on the pre-determined
This journal is © The Royal Society of Chemistry 2019
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View Article Onlinethis biouid, see Fig. S27.† A highly linear calibration curve (R2¼
0.996) was obtained by the stepwise addition of 75 aliquots of
memantine (nal concentration of 0.12 mM to 8.3 mM) to bovine
blood serum that was spiked with 9.9 mM CB8IMPCP, see
Fig. S28.† It is worth noting that deviations from the linearity are
to be expected for IDAs when the analyte concentration
approaches that of the reporter pair. Indeed, Fig. S29† shows this
behavior both for the simulated and experimentally observed
calibration curve in human blood serum.
Also in human blood serum the analyte Mem could be quan-
tied at a sub- to low micromolar concentration (Fig. 5C, cali-
bration curve with R2 ¼ 1.000), covering the physiological
concentration range of memantine during Alzheimer's treatment.
Moreover, we observed that a calibration curve obtained in PBS
could be overlaid with the calibration curve obtained in human
blood serum and in bovine blood serum, Fig. 5C & S30,† by
shiing the y-axis oﬀset to account for diﬀerent absolute emission
intensities originating from background emission and inner lter
eﬀects in the diﬀerent media. Likewise, the inuence of sample-
to-sample matrix variation diﬀerences was tested by repeating the
calibration curve measurement (0 to 2 mM memantine) in
diﬀerent bovine blood serum batches (Table S4†). The slopes of
the memantine calibration curves were very similar (#10%
diﬀerence to the mean) between the three bovine blood serum
batches tested, which agrees well with the predictions from the
binding isotherm simulations (see Fig. 3C) and meets an impor-
tant prerequisite for the development of a quantitative analytical
memantine assay. Utilising the pre-determined calibration
curves, we then succeeded in detecting unknown concentrations
of memantine in spiked human blood serum with relatively high
accuracy, see Fig. 5C. We believe that sample-to-sample diﬀer-
ences caused by photophysical eﬀects (e.g. inner lter eﬀects) are
the main cause for the remaining uncertainties when using the
CB8IMPCP indicator pair. To emphasize, a memantine cali-
bration curve obtained in pig blood serum showed a much
steeper albeit still linear calibration curve (R2 ¼ 0.999), Fig. S31.†
It has to be noted that pristine bovine blood serum and pig blood
serum not only diﬀer in their molecular composition but also
strongly in their cloudiness and optical properties (absorbance
and emission spectra). Future eﬀorts will be therefore directed
towards the development of brighter MPCP derivatives that are
excitable at$450 nm and that show higher emission on–oﬀ ratios
upon CB8 binding in order to establish an emission-background
independent memantine assay.
Experimental
General materials and methods
All solvents were used as received from Aldrich or Fluka without
any further purication. The compounds were puried by
column chromatography using silica gel 60 (230–400 mesh,
Merck Millipore) as the stationary phase. 1H and 13C NMR
spectra were recorded on a Bruker AM 400 or a Bruker Avance
500 spectrometer at room temperature. The 1H NMR chemical
shis (d) are given in ppm and refer to residual protons on the
corresponding deuterated solvent: chloroform (7.26 ppm in 1H;
77.0 ppm in 13C) and water (4.79 ppm in 1H; no signal in 13C).This journal is © The Royal Society of Chemistry 2019The assignments of the signal structure in 1H NMR were made
by the multiplicity and for 13C NMR by DEPT90- and DEPT 135-
spectra (DEPT ¼ distortionless enhancement by polarization
transfer) with + ¼ primary or tertiary C-atom (positive DEPT-
signal),  ¼ secondary C-atom (negative signal) and Cq. ¼
quaternary C-atom (no signal). All deuterated solvents were
used as received without any further purication. All coupling
constants (J) are given in hertz (Hz). IR spectra were recorded on
a FT-IR Bruker IFS 88 spectrometer. The compounds were
measured as pure substances by the ATR technique (ATR ¼
attenuated total reection). The intensities of the bands were
characterized as follows: vs ¼ very strong (0–20% T), s ¼ strong
(21–40% T), m ¼ medium (41–60% T), w ¼ weak (61–80% T),
and vw ¼ very weak (81–100% T). Mass spectrometry (MS)
experiments were performed on a Bruker Daltonics micro-Q-
ToF II spectrometer equipped with an orthogonal electrospray
(ESI) interface or on a Finnigan MAT 95 (EI-MS). The peaks are
given as mass-to-charge-ratio (m/z). The molecule peak is given
as [M]+ and characteristic fragment peaks are given as [M 
fragment]+ or [fragment]+. The signal intensities are given
relatively (in percent) to the intensity of the base signal (100%).
Absorption spectra were recorded on a Jasco V-730 double-
beam UV-VIS spectrophotometer and baseline corrected.
Steady-state emission spectra and time resolved emission
proles were recorded on a Jasco FP-8300 uorescence spec-
trometer equipped with a 450W xenon arc lamp, double-grating
excitation, and emission monochromators. Emission and exci-
tation spectra were corrected for source intensity (lamp and
grating) and the emission spectral response (detector and
grating) using standard correction curves. For spectral
recording the automatic lter change of the FP-8300 was
applied avoiding second order diﬀraction artefacts. Titration
curves were recorded using a Jasco FP-8300 uorescence spec-
trometer equipped with an ATS-827 automatic titration unit
lled with the appropriate compound (host/guest) and subse-
quently corrected for dilution. All titration and kinetic experi-
ments were carried out at T ¼ 25 C by using a water
thermostatted cell holder STR-812, while the cuvettes were
equipped with a stirrer allowing rapid mixing. For spectroscopy
analysis in quartz cuvettes, suprasil (type 111-QS) emission
cuvettes with a light path of 10 mm and dimensions of 10  10
mm from Hellma-Analytics were utilized. For titration experi-
ments PMMA cuvettes with a light path of 10 mm and dimen-
sions of 10  10 mm from Brand with a spectroscopic cut-oﬀ at
300 nm were utilized.DFT calculations
Density functional theory (DFT) calculations have been carried
out in order to evaluate the ground state structure of the
inclusion complex between CB8 and MPCP as well as CB7 and
MPCP. DFT calculations were carried out utilizing the hybrid
functional B3LYP with the standard valence basis set 6-31G(d,p)
for C,H,N and O. The found stationary points possess no
imaginary frequencies and therefore assumed to be true
minima. All calculations were performed with the program
package G16.B.01.63Chem. Sci., 2019, 10, 6584–6593 | 6589
Table 2 Summary of the photophysical parameters of MPCP and its
inclusion complex with CB8 under ambient conditions in water
Technique Quantity/unit MPCP CB8IMPCP
Absorbance labs,max/nm 335 342
3lmax/M
1 cm1 7111 (190) 5653 (152)
lisosbestic/nm 366
Fluorescence lem,max/nm 535 542
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View Article OnlineSynthesis of methyl-pyridinium-paracyclophane (MPCP)
PyPCP (50.0 mg, 180 mmol, see ESI† for synthesis) was dissolved
in 1.5 mL dichloromethane in a one neck round bottom ask
equipped with a magnetic stirrer. Subsequently, 1 mL of methyl
iodide (2.28 g, 16.1 mmol) was added under ambient
conditions resulting in a pale yellow solution. The crude
mixture was allowed to react for 72 h, while two portions of
methyliodide (1 mL) were additionally added aer 24 h and 48
h. The crude reaction mixture was extracted three times with
water. Aer the removal of water by lyophilization, MPCP was
obtained as a yellow powder (42.1 mg, 98.5 mmol, yield: 54.7%).
1H NMR (500MHz, D2O) d¼ 8.76 (d, J¼ 6.4, 2H), 8.14 (d, J¼ 6.5,
2H), 6.86 (d, J ¼ 11.5, 3H), 6.80–6.68 (m, 3H), 6.53 (d, J ¼ 7.9,
1H), 4.38 (s, 3H), 3.45–3.35 (m, 1H), 3.25–3.06 (m, 5H), 3.03–2.94
(m, 1H), 2.62–2.52 (m, 1H). 13C NMR (126 MHz, D2O): d ¼ 144.6
(+, CH), 141.6 (Cq.), 140.6 (Cq.), 140.0 (Cq.), 138.8 (Cq.), 137.0 (+,
CH), 135.9 (+, CH), 135.8 (Cq.), 133.7 (+, CH), 133.2 (+, CH), 132.4
(+, CH), 131.8 (+, CH), 129.5 (+, CH), 127.7 (+, CH), 47.2 (+, CH3),
34.6 (, CH2), 34.3 (, CH2), 34.2 (, CH2), 33.4 (, CH2) ppm.
IR (ATR) n ¼ 3386 (vw), 3032 (vw), 2920 (vw), 2850 (vw), 2573
(vw), 2322 (vw), 2168 (vw), 2020 (vw), 1918 (vw), 1639 (vw), 1516
(vw), 1454 (vw), 1332 (vw), 1198 (vw), 1096 (vw), 949 (vw), 843 (w),
720 (vw), 642 (vw), 488 (vw) cm1. HRMS (ESI, C22H22N
+) calc.
300.1747, found 300.1737. EA (C22H22IN$5H2O) calc. C 51.06%,
H 4.29%, N 2.71%; found C 50.90%, H 4.29%, N 2.81%.Photophysical studies
The electronic absorption spectrum of MPCP in water is dis-
played in Fig. S11.† The high energy transitions at 225 nm and
255 nm are ascribed to the p/ p* transitions localized on the
[2.2]paracyclophane scaﬀold. The low energetic transition
peaking at 351 nm is assigned to an intramolecular charge-
transfer p / p* transition (ITC) band from the [2.2]para-
cyclophane to the methylated pyridinium entity.MPCP displays
room temperature emission peaking at 545 nm in aqueous
solution. The acquired excitation spectrum is in good agree-
ment with the corresponding absorption spectrum (Table 2).Supramolecular host–guest binding studies
In order to obtain binding isotherms suitable for a meaningful
tting of the binding constant, competitive uorescence titra-
tion experiments were carried out. Firstly, the binding constants
of the complex formation of CB8IBC2 were determined by
uorescence titration experiments with a subsequent binding
model on the basis of eqn (1)–(4) (a is the corresponding
emission intensity factor xed by the quantum yield ratio for
aHDD and typically results in 0 for aD) in very good agreement
with literature values from Biczok et al. (see Table S3†).64
Secondly, the binding isotherms of ultra-high aﬃnity guests
such as MPCP and Mem were obtained by an IDA with
CB8IBC2. The isotherms were tted to a binding model
derived from eqn (1) to (3) and (5) to (7) and the value of the
corresponding Ka determined as the mean (standard devia-
tion) of ten independent titration experiments (see ESI† for
titration data).6590 | Chem. Sci., 2019, 10, 6584–6593I emsignal ¼ aHD[HD] + aHDD[HDD] + aD[D] (1)
KHDa ¼
½HD
½H½D K
HDD
a ¼
½HDD
½HD½D (2)
[D]0 ¼ [D] + [HD] + 2[HDD] (3)
[H]0 ¼ [H] + [HD] + [HDD] (4)
KHGa ¼
½HG
½H½G (5)
[G]0 ¼ [G] + [HG] (6)
[H]0 ¼ [H] + [HD] + [HDD] + [HG] (7)Mathematical simulations of binding isotherms
In order to simulate matrix eﬀects in a complex medium such as
blood, a pure competitive behavior of the interferents was
assumed. The binding aﬃnities of compounds in blood serum
potentially interacting with CB8 were estimated by a critical
review of the literature (Fig. 6). The lower and upper limits of
blood serum were approximated to be similar to the ranges
known for serum.51
The competitive model was developed on the basis of a non-
linear algebraic system composed of thermodynamic expres-
sions of the equilibrium constants of the individual interferents
and the reporter dye with the host CB8 derived from their law of
mass action, the corresponding conservations of mass equa-
tions. Eqn (8)–(10) describe the algebraic system to be solved.
The system was numerically solved to [HD] as signal expression
using the soware Wolfram Mathematica. For the simulations
displayed in this work, the binding constant of the HD complex
was varied for each individual IDA titration with increasing
Mem concentration.
KHGia ¼
½HGi
½H½Gi K
HD
a ¼
½HD
½H½D (8)
[Gi]0 ¼ [Gi] + [HGi] [D]0 ¼ [D] + [HD] (9)
½H0 ¼ ½H þ ½HD þ
X
i
½HGi (10)This journal is © The Royal Society of Chemistry 2019
Fig. 6 Typical interferents for competitive interactions with CB8 in
blood serum. The concentration ranges are depicted as they typically
appear in serum.51 The logarithmic binding constants are approxi-
mated values derived from literature values: steroids,35 putrescine/
spermidine,3,58 amino acids,33,65 hexosamines,66 cholesterol,35 fatty
acids,67,68 and metal cations.3,69 Intermolecular interaction parameters
for CBn complexes can be found in the SupraBank repository.70
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View Article OnlineConclusions
In this study, we provided the rst proof-of-principle report for
the in situ detection and quantication of Alzheimer's drug
memantine in blood serum through an emission-based supra-
molecular indicator-displacement assay (IDA). We showed that
a high-aﬃnity but unselective host, such as cucurbit[8]uril
(CB8), cannot be used in a direct-binding assay because of
nearly complete, undesirable complex saturation with the
naturally occurring interferents in blood serum. Conversely,
unselective binding hosts can be utilized for sensing applica-
tions in complex, competitively binding biouids through the
IDA. However, this is only possible if both the aﬃnity of the
analyte of interest is higher than that of the interferents, and if
suitable reporter dyes with a narrowly dened binding aﬃnity
range are available. Previously reported indicator dyes for CB8
were not suitable for sensing application in blood serum
because they fall short in binding strength, causing high
susceptibility to naturally occurring sample-to-sample varia-
tions in the blood compositions.
We have introduced here a new class of ultra-high-aﬃnity,
emissive indicator dyes for CB8 which is based on a [2.2]para-
cyclophane moiety that is connected to a pyridinium group.
This design ensured ultra-strong binding to CB8 (log Ka¼ 12.59
in water) and provided an environment-polarity sensitive CT-
type emission signal read out with a desirable, very high Stokes
shi (ca. 200 nm). With this new dye class, a CB8-based che-
mosensing ensemble for sensing applications at physiologically
relevant memantine concentrations in the chromophoric andThis journal is © The Royal Society of Chemistry 2019autoemissive blood serum could be developed. This is to our
knowledge the rst working example of a cucurbit[n]uril-based
sensing assay in blood serum, and ranges amongst the most
analyte-concentration sensitive assays reported to date that are
based on purely synthetic hosts. We believe that similar
concepts can be successfully applied for designing and devel-
oping blood-serum based supramolecular assays starting from
emerging synthetic high-aﬃnity supramolecular host
systems.71–77
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